Timothy J. Triche

Dr. Triche has been the Director of the Center for Personalized Medicine at Children’s Hospital Los Angeles since July 2010 and previously served as the Chairman of the Department of Pathology and Laboratory Medicine at Children’s Hospital Los Angeles since 1988. He has also been a Professor of Pathology and Pediatrics at the University of Southern California Keck School of Medicine in Los Angeles, California since 1988. He also serves on the Board of Directors of Novelix Pharmaceuticals, Inc., a private California-based biotechnology company, NanoValent Pharmaceuticals, Inc., a private nanotechnology company, GenomeDx, a private Canadian biotechnology company developing prognostic tests for cancer, Silicon Valley Biosystems, a private California-based biotechnology company, and Sanguine BioSciences, a private biomedical research company.

Dr. Triche brings to the Board of LTC Properties, Inc. his experience as current and past executive and director experience with other health care companies and his overall background in the health care industry.